References
- Mameli C, Genoni T, Madia C, Doneda C, Penagini F, Zuccotti G. Brain abscess in pediatric age: a review. Childs Nerv Syst. 2019;35:1117–28.
- Omar AT, 2nd, Khu KJO. Successful management of intraventricular rupture of pyogenic brain abscess (IVROBA): Systematic review and illustrative case. J Clin Neurosci. 2020;71:191–8.
- Liu SP, Xiao J, Liu YL, et al. Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections. Front Pharmacol. 2022;13:1056148.
- Petti CA, Simmon KE, Bender J, et al. Culture-Negative intracerebral abscesses in children and adolescents from Streptococcus anginosus group infection: a case series. Clin Infect Dis. 2008;46:1578–80.
- Watson M. Streptococcal Intermedius Brain Abscesses In An Adolescent Male With Histoplasma Infection. Pediatric Oncall. 2012;9.
- Bodilsen J, D’Alessandris QG, Humphreys H, et al. European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infect. 2024;30:66–89.
- Bonilla FA. Interpretation of lymphocyte proliferation tests. Ann Allergy Asthma Immunol. 2008;101:101–4.
- Nagl M, Neher C, Hager J, Pfausler B, Schmutzhard E, Allerberger F. Bactericidal activity of vancomycin in cerebrospinal fluid. Antimicrob Agents Chemother. 1999;43:1932–4.
- Reiter PD, Doron MW. Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants. J Perinatol. 1996;16:331–5.
- Doan N, Nguyen H, Luyuan L, Shabani S, Gelsomino M, Johnson V. Good Outcomes with the Intraventricular Vancomycin Therapy in a Patient with Ruptured Brain Abscesses. Asian J Neurosurg. 2018;13:396–9.
- Deniz M, Tapısız A, Börcek A, Tezer H. Intraventricular treatment of paediatric meningitis due to extensively drug-resistant Gram-negative bacteria: two case reports and review of the literature. J Chemother. 2021;33:509–16.
- Parasuraman JM, Albur M, Fellows G, Heep A. Monitoring intraventricular vancomycin for ventriculostomy access device infection in preterm infants. Childs Nerv Syst. 2018;34:473–9.
- Bafeltowska JJ, Buszman E, Mandat KM, Hawranek JK. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections. Surg Neurol. 2004;62:142–50; discussion 50.
- Ng K, Mabasa VH, Chow I, Ensom MH. Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults. Neurocrit Care. 2014;20:158–71.